Folia Cardiologica nr 3/tom 12/2017

PRACA KAZUISTYCZNA

Raynaud’s phenomenon as a predictor of a rare type of coronary artery disease – Prinzmetal angina

Fenomen Raynauda jako czynnik przepowiadający rzadką postać choroby wieńcowej – dławicę naczynioskurczową Prinzmetala

Andrzej Jakub Sałacki1, 2, Andrzej Wysokiński2

1II Faculty of Medicine with English Language Division, Medical University of Lublin, Poland

2Chair and Department of Cardiology, Medical University of Lublin, Poland

Address for correspondence: prof. dr hab. n. med. Andrzej Wysokiński, Katedra i Klinika Kardiologii, Uniwersytet Medyczny, ul. Jaczewskiego 8, 20–954 Lublin, tel. +48 81 724 41 51, e-mail: a.wysokinski@umlub.pl

Abstract

This is a case of a man referred from a primary care facility to an emergency department because he had strong pains of the spine that had already been present for 2 weeks. He was hospitalized in an endocrinology clinic due to his uncontrolled diabetes. During this stay, he had several Raynaud’s syndrome attacks. Very soon after an attack he felt a strong and characteristic pain in his chest. The angiography of coronary vessels was performed when the patient was experiencing pain showed a spasm in the initial part of the left anterior descending artery which later stopped after an intracoronary nitroglycerin dose was administered. Markers of myocardial necrosis were not increased. This clinical picture and results of additional tests point towards Prinzmetal angina (coronary vessel spasm). The interesting thing is that the pain in the chest was always preceded by a paroxysmal arterial spasm in the fingers which also turned pale and the patient experienced a “pins and needles” sensation. Then the skin would turn blue and then red and later burn. The drug therapy which, following our decision, was the same in both cases, eliminated the ailments of the chest and fingers.

Key words: Prinzmetal’s angina, Raynaud’s phenomenon, calcium channel blockers

Folia Cardiologica 2017; 12, 3: 285–290

Introduction

Prinzmetal angina (PA) is a rare form of the coronary vessel spasm ischemic heart disease [1]. It results in a local spasm of the big epicardial coronary artery [2]. The exact cause of the spasm has not been established yet, however, it is most likely related to the dysfunction of the endothelium, hypersensitivity of the vascular smooth muscle, increased tension of the autonomic system or oxidative stress [3]. Spasms might pass to both healthy arteries and arteries with atherosclerotic lesions [4, 5]. The type of angina described by Prinzmetal in 1959, with the help of an outstanding Polish expert Jan Kwoczyński, might pass with a varied clinical picture in the case of the same patient. It is prevalent in patients who are from 50 to 60 years old. Smoking is the major risk factor in the case of the epicardial vessel spasm [6–9]. AP appears most often when the body is resting and has no casual link with situations where the heart muscle has an increased need for oxygen.

Case description

A 60-year-old patient was transferred to an endocrinology clinic from an emergency department due to high hyperglycemia, about 390 mg/dL. The patient had been treated for diabetes type 2 for 4 years, he is obese, does not follow the diabetic diet and has been addicted to smoking for 30 years. He is a professional driver. His medical history shows that in 2002 he underwent an ischaemic brain stem stroke. At present, he shows a partial hemiparesis of the left side. The patient has been complaining about joint pains for 2 weeks, especially spine joints and he also reported temporary sensation of pins and needles in his hand as well as bone and joint aches in that area. In a primary care facility he had been treated with non-steroidal anti-inflammatory drugs. Moreover, he was treated for hypertension and hypercholesterolemia. He was given the following drugs: aspirin 75 mg, carvedilol 25 mg, rampiril 10 mg, metformin 2 × 500 mg, methylprednisolone 16 mg, rosuvastatin 10 mg, paracetamol 325 mg + tramadol 37,5 mg. Physical examination results – regular heart action at about 75/min, loud heart sounds, blood pressure at about 130/80 mm Hg. Laboratory test showed concentration of uric acid 7.40 mg/dL, CRP 146 mg/L, WBC 11 thousand/mm3. Three times during the stay in the endocrinology clinic, the patient reported his fingers turning pale, then violet and then turning red which lasted for few minutes (according to the doctors conducting the 2nd stage following the Taylor-Pelmear scale). In the initial phase, hands become pale and blood does not run through finger vessels due to the hand spasm. Then, small blood vessels expand and fill with blood which is devoid of oxygen and because of that the color of hands turns violet. Finally, the color of hands becomes red because of the increasing blood flow in vessels, after the spasm subsides [10]. After all three stages, the patient experienced pain in the chest of typical nature and extending to the left upper limb, which would stop after few minutes and always occurred at night. Because of coronary symptoms with an unclear cause, the patient was transferred to an intensive care unit. During his stay, early in the morning, he experienced severe pains in his chest, typical for ischemia and preceded by the Raynaud’s syndrome attack. The ECG taken when he was experiencing the pain is showed in Figure 1. The patient had coronary angiography which showed a spasm in the proximal part of the anterior interventricular branch of the left coronary artery (Fig. 2), which subsided after an intracoronary nitroglycerin dose was administered; it also showed mural lesions in other vessels (Fig. 3). The collected troponin was negative (< 0.006 ng/mL). The ECG (Fig. 4) taken 20 minutes after the pains subsided showed normalization of the ST segment in leads from the anterior wall, where the left anterior descending artery is responsible for the blood flow. Due to the above reasons, conservative treatment was recommended as a course of action. Transthoracic echocardiography showed a 60% ejection fraction of the left ventricle, mitral valve insufficiency of the 2nd level and 3rd tricuspid level. A calcium channel blocker was incorporated into the treatment (diltiazem 2 × 120 mg). Administration of beta blockers was stopped because they were intensifying PA symptoms. The same was applied to aspirin as it could intensify symptoms and inhibit prostacyclin production, a natural vasodilator. Coronary ailments did not return after the drug therapy. No new Raynaud’s syndrome attacks were observed. Since there was a possibility of PA complications due to cardiac and conduction arrhythmia or a sudden cardiac death, the Holter monitor test was conducted. It registered only 10 additional instances of activation of supraventricular nature. The patient was transferred to his primary clinic in a stable condition to continue the treatment of metabolic disorders.

ryc10-1a.jpg

ryc10-1b.jpg

Figure 1A, B. ECG conducted while the patient was experiencing pain. Sinus rhythm 65/min. ST-segment elevation in lead V1–V5 with a contrasting depression in leads II, III, aVF

ryc10-2.jpg

Figure 2. Spasm in the LAD initial segment

ryc10-3.jpg

Figure 3. Diastole of the LAD initial segment after intracoronary nitroglycerin dose was administered

ryc10-4a.jpg

ryc10-4b.jpg

Figure 4A, B. ECG conducted 20 minutes after coronary pain. Normalization of ST elevations in leads V1–V5, with negative T waves in leads aVL, V1–V4

Discussion

Prinzmetal angina occurs in Poland in less than 1% of the patients with signs of angina. Its frequency rate is from 3% to 5% of the general population and the average age of patients is 47.2 [11, 12]. In the Nakamura test [13], the prevalence of migraine and RS among Japanese patients with PA was assessed. Three groups were created. The first one included patients with PA, the second one included the ones with exercise-induced angina and the third group included patients without an ischemic heart disease. Each group had 100 patients and there were no significant differences between them with respect to age and sex. The migraine frequency rate in Japanese patients with PA was 23%, while in the group with exercise-induced angina and in the control group it was 4% and 11%, respectively [14, 15]. The prevalence of RS in the first group was 9%, in the second group it was 3% and in the third group it was 4%, which shows that the differences were not considerable. The Miller & Associates Test [16] carried out on patients in the Northern America, showed that the prevalence of migraine was 26% in 62 patients with PA and that was a considerably bigger number than in the case of the coronary group (6%) and the control group with no coronary disease (10%). In the test, the prevalence of RS was as much as 24% in patients with PA, while it was 5% in the coronary group and 3% in the non-coronary control group. In Korea, Koh and associates [17] proved that the prevalence of migraine (40%) and RS (10%) in 20 patients with PA did not significantly differ from the one in patients with coronary disease and patients without it. The frequency of migraines in those patients was compliant with the tests carried out by Miller, unlike RS. The number of patients with PA was lower in comparison with the Miller’s test. The differences in results of Japanese and American researchers, and especially those concerning the number of RS cases in patients with PA, may be the result of racial and climate differences as the tests were carried out in Kanazawa and Toyama in Japan and Montreal in Northern America where it is colder. Low temperature was the predisposing factor for both PA and RS. The fact that exposure to cold caused RS is probably related with the additional increase in biosynthesis of thromboxane A2, which is a factor narrowing blood vessels [18, 19]. There are many other theories which try to explain the pathophysiological mechanism of PA. One of them stated that the symptoms of the disease may result from disorders of oxide of nitrogen production which physiologically causes the increase of the cyclic guanosine monophosphate through guanylyl cyclase activation and thus causes vasodilation effects. It is also suppressive with respect to endothelin and angiotensins II production, which have vasoconstrictive effect. Acetylcholine is the next chemical substance which may play its part in the patomechanism of vasospasm. In the case of vessels with no damage to endothelium, it widens them through the oxide of nitrogen, but when there is damage, it has a vasoconstrictive effect. Also, an excessive activity of phospholipase C plays its part in pathophysiology of PA, which may cause smooth muscle spasm by shifting calcium ions from the extracellular space [1, 20–23].

The case of the patient described as the last one shows standard risk factors of coronary disease. Moreover, the patient was addicted to smoking cigarettes, which plays an important role in PA etiology. In the above mentioned Nakamura test [13], as many as 44% of PA patients smoked cigarettes. The confirmation of the diagnosis in the instance described is the ECG recording done when the patient was experiencing pain in the chest, as well as the spasm of the epicardial coronary artery present in coronary catheterization which decreased after intracoronary application of nitroglycerine and also the lack of increasing markers of the heart muscle necrosis. Temporary elevation of the ST segment in the ECG recording occurred in the leads correspondent to vessels experiencing spasms. The nature and time of symptoms were characteristic for PA and suggested that angina ailments are not connected with the disproportion between the heart muscle’s demand for oxygen and its supply. This hypothesis is confirmed by the fact that PA symptoms increased after administering beta blockers. It was replaced with blockers of the calcium channel in a big dosage and this brought positive clinical effects. The factor conducive to RS, except for factors common with PA, was the profession of a driver and the microinjuries connected therewith which occurred during a constant contact of the driver’s hands with the wheels of his vehicles.

The case described is a very rare situation where episodes of Prinzmetal angina are preceded by Raynaud’s disease attacks. The course of PA, favorably for the patient, was not complicated by a heart attack or a dangerous arrhythmia. Clinical symptoms related with RS attacks were a signal for the patient that angina ailments could occur. As they did not recur, the case shows high efficiency of pharmacological treatment, the same in the case of both diseases.

Streszczenie

Opisany przypadek dotyczy mężczyzny skierowanego na szpitalny oddział ratunkowy z podstawowej opieki zdrowotnej z powodu silnych dolegliwości bólowych kręgosłupa występujących od 2 tygodni. Ze względu na niewyrównaną cukrzycę był on hospitalizowany w klinice endokrynologii. W trakcie tego pobytu kilkukrotnie wystąpił u niego napad zespołu Raynauda. Wkrótce po incydencie chory odczuwał bardzo silny i typowy ból w klatce piersiowej. W angiografii naczyń wieńcowych wykonanej w momencie trwającego bólu stwierdzono skurcz w początkowym odcinku gałęzi międzykomorowej przedniej lewej tętnicy wieńcowej, który ustąpił po dowieńcowym podaniu nitrogliceryny. Markery martwicy mięśnia sercowego nie były podwyższone. Powyższy obraz kliniczny, w połączeniu z wynikami badań dodatkowych, przemawiał za dławicą Prinzmetala (naczynioskurczową). Interesujący jest fakt, że dolegliwości bólowe występujące w klatce piersiowej za każdym razem poprzedzał napadowy kurcz tętnic palców dłoni z ich zblednięciem i mrowieniem, a następnie zasinieniem i, kolejno, zaczerwienieniem oraz pieczeniem skóry. Zastosowana farmakoterapia, z wyboru w obu przypadkach taka sama, pozwoliła na ustąpienie dolegliwości zarówno ze strony klatki piersiowej, jak i palców dłoni chorego.

Słowa kluczowe: dławica Prinzmetala, fenomen Raynauda, antagoniści wapnia

Folia Cardiologica 2017; 12, 3: 285–290

References

1. Salwa P, Wożakowska-Kapłon B. Zawał serca w przebiegu dławicy naczynioskurczowej u 57-letniego mężczyzny. Choroby Serca i Naczyń. 2011; 8(1): 43–47.

2. Szczeklik A. Choroby wewnętrzne. Przyczyny, rozpoznanie i leczenie, vol. I. Medycyna Praktyczna, Kraków 2005.

3. Seniuk W, Mularek-Kubzdela T, Grygier M, et al. Cardiac arrest related to coronary spasm in patients with variant angina: a three-case study. J Intern Med. 2002; 252(4): 368–376, indexed in Pubmed: 12366610.

4. Pasierski T. Choroba niedokrwienna serca. In: Szczeklik A, Tendera M. ed. Kardiologia. Medycyna Praktyczna, Kraków 2009: 363–364.

5. Sosnowska-Pasiarska B, Wożakowska-Kapłon B. Dławica naczynioskurczowa, manifestacja kliniczna u 79-letniego chorego z miażdżycą tętnic wieńcowych. Kardiol Pol. 2007; 65: 1101–1107.

6. Zipes DP, Libby P, Bonow RO, Braunwald EA. A textbook of cardiovascular medicine. 5th ed. Elsevier Saunders, Philadelphia 1997: 1340–1343.

7. Beltrame J. Dławica piersiowa odmienna typu Prinzmetala: spojrzenie współczesne. In: Braunwald E. ed. Postępy w kardiologii Harrisona. Wydawnictwo Czelej, Lublin 2005: 254–260.

8. Armstrong PW. Acute Ischemic Syndromes. In: Topol EJ. ed. Comprehensive Cardivascular Medicine. Lippincott – Raven Publishers, Philadelphia–New York 1998: 370–373.

9. Braunwald E. Rozpoznanie i postępowanie w niestabilnej chorobie wieńcowej i zawale serca bez uniesienia odcinka ST. In: Braunwald E, Goldman L. ed. Kardiologia. 1st ed. Wydawnictwo Medyczne Urban & Partner, Wrocław 2005: 472–473.

10. Ratchford EV, Evans NS. Raynaud’s phenomenon. Vasc Med. 2015; 20(3): 269–271, doi: 10.1177/1358863X15579122, indexed in Pubmed: 25878215.

11. Szczeklik A, Tendera M. Kardiologia. Medycyna Praktyczna, Kraków 2009.

12. Kowal-Bielecka O, Bielecki M. Choroba i zespół Raynauda. In: Puszczewicz M. ed. Reumatologia. Medical Tribune Polska, Warszawa 2010: 409–419.

13. Prete M, Fatone MC, Favoino E, et al. Raynaud’s phenomenon: from molecular pathogenesis to therapy. Autoimmun Rev. 2014; 13(6): 655–667, doi: 10.1016/j.autrev.2013.12.001, indexed in Pubmed: 24418302.

14. Warshaw LJ, Lipton RB, Silberstein SD. Migraine: a “woman’s disease?”. Women Health. 1998; 28(2): 79–99, indexed in Pubmed: 10067807.

15. Honkasalo ML, Kaprio J, Heikkilä K, et al. A population-based survey of headache and migraine in 22,809 adults. Headache. 1993; 33(8): 403–412, indexed in Pubmed: 8262779.

16. Miller D, Waters DD, Warnica W, et al. Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med. 1981; 304(13): 763–766, doi: 10.1056/NEJM198103263041306, indexed in Pubmed: 7464885.

17. Koh KK, Kim SH, Lee KH, et al. Does prevalence of migraine and Raynaud’s phenomenon also increase in Korean patients with proven variant angina? Int J Cardiol. 1995; 51(1): 37–46, indexed in Pubmed: 8522395.

18. Gasser P. Clinical syndromes with vasoconstrictor response. Wien Klin Wochenschr. 1991; 103(8): 217–221, indexed in Pubmed: 1858387.

19. Fredrick M, Wigley MD. Raynaud’s phenomenon. Current Opinion in Rheumatology. 1993(5): 773–784.

20. Boulanger C, Lüscher TF. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest. 1990; 85(2): 587–590, doi: 10.1172/JCI114477, indexed in Pubmed: 2153712.

21. Takemoto M, Egashira K, Usui M, et al. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest. 1997; 99(2): 278–287, doi: 10.1172/JCI119156, indexed in Pubmed: 9005996.

22. Furchgott RF, Furchgott RF. Role of endothelium in responses of vascular smooth muscle. Circ Res. 1983; 53(5): 557–573, indexed in Pubmed: 6313250.

23. Itoh T, Mizuno Y, Harada E, et al. Coronary spasm is associated with chronic low-grade inflammation. Circ J. 2007; 71(7): 1074–1078, indexed in Pubmed: 17587713.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl